GlucoTrack, Inc. (GCTK) vs Genprex, Inc. (GNPX)
A side-by-side comparison of GlucoTrack, Inc. and Genprex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GCTK
GlucoTrack, Inc.
$1.12HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
GNPX
Genprex, Inc.
$2.59HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — GCTK vs GNPX
growth of $100 · dividends reinvested · last 9yGCTK -100.0% (-80.1%/yr)GNPX -100.0% (-71.3%/yr)GNPX compounded faster over this window
Log scale — wide-divergence pair
GCTK GNPX
GCTK vs GNPX: by the numbers
- •GNPX is the larger company ($1M vs $893920 market cap).
Metrics side by side
Valuation
| Metric | GCTK | GNPX |
|---|---|---|
| P/B ratio | N/A | 0.09 |
Profitability
| Metric | GCTK | GNPX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -111.51% |
| ROIC | N/A | -107.08% |
Growth (annualized)
| Metric | GCTK | GNPX |
|---|---|---|
| Total return CAGR (5Y) | -92.60% | -88.16% |
Frequently asked
- How have GCTK and GNPX total returns compared?
- Over the past 5 years, GCTK delivered -92.60% and GNPX delivered -88.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.